Faulty genomic pathway linked to schizophrenia developing in utero, study finds

February 27, 2017 by Ellen Goldbaum
Credit: University at Buffalo

The skin cells of four adults with schizophrenia have provided an unprecedented "window" into how the disease began while they were still in the womb, according to a recent paper in Schizophrenia Research.

The paper was published online in January by researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in collaboration with the Icahn School of Medicine at Mount Sinai. It provides what the authors call the first proof of concept for their hypothesis that a common genomic pathway lies at the root of schizophrenia.

The researchers say the work is a first step toward the design of treatments that could be administered to pregnant mothers at high risk for bearing a child with schizophrenia, potentially preventing the disease before it begins.

Multiple mutations

"In the last 10 years, genetic investigations into schizophrenia have been plagued by an ever-increasing number of mutations found in patients with the disease," said Michal K. Stachowiak, PhD, senior author on the paper, and professor in the Department of Pathology and Anatomical Sciences in the Jacobs School of Medicine and Biomedical Sciences at UB.

PHOTO available here.

"We show for the first time that there is, indeed, a common, dysregulated gene pathway at work here," he said.

The authors gained insight into the early brain pathology of schizophrenia by using from four adults with schizophrenia and four adults without the disease that were reprogrammed back into induced pluripotent stem cells and then into neuronal progenitor cells.

"By studying induced pluripotent developed from different patients, we recreated the process that takes place during early brain development in utero, thus obtaining an unprecedented view of how this disease develops," said Stachowiak. "This work gives us an unprecedented insight into those processes."

A central intersection point

The research provides what he calls proof of concept for the hypothesis he and his colleagues published in 2013. They proposed that a single genomic pathway, called the Integrative Nuclear FGFR 1 Signaling (INFS), is a central intersection point for multiple pathways involving more than 100 genes believed to be involved in schizophrenia.

"This research shows that there is a common dysregulated gene program that may be impacting more than 1,000 genes and that the great majority of those genes are targeted by the dysregulated nuclear FGFR1," Stachowiak said.

When even one of the many -linked genes undergoes mutation, by affecting the INFS it throws off the development of the brain as a whole, similar to the way that an entire orchestra can be affected by a musician playing just one wrong note, he said.

The next step in the research is to use these induced to further study how the genome becomes dysregulated, allowing the disease to develop.

"We will utilize this strategy to grow cerebral organoids - mini-brains in a sense - to determine how this genomic dysregulation affects and to test potential preventive or corrective treatments," he said.

Explore further: Stem cell research helps to identify origins of schizophrenia

More information: S.T. Narla et al, Common developmental genome deprogramming in schizophrenia—Role of Integrative Nuclear FGFR1 Signaling (INFS), Schizophrenia Research (2017). DOI: 10.1016/j.schres.2016.12.012

Related Stories

Stem cell research helps to identify origins of schizophrenia

January 22, 2013
New University at Buffalo research demonstrates how defects in an important neurological pathway in early development may be responsible for the onset of schizophrenia later in life.

Study provides clues to relationship between schizophrenia and rheumatoid arthritis

February 24, 2017
An in-depth computational analysis of genetic variants implicated in both schizophrenia and rheumatoid arthritis by researchers at the University of Pittsburgh points to eight genes that may explain why susceptibility to ...

Powerful genetic regulator identified as risk factor for schizophrenia

April 21, 2016
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed ...

Schizophrenic stem cells do not differentiate properly into neurons

November 1, 2016
Researchers at the RIKEN Brain Science Institute have used human-induced pluripotent stem cells (hiPSCs) to identify a characteristic of abnormal brain development in schizophrenia. Published in Translational Psychiatry, ...

Structural brain connectivity as a genetic marker for schizophrenia

November 25, 2015
Schizophrenia has been considered an illness of disrupted brain connectivity since its earliest descriptions. Several studies have suggested brain white matter is affected not only in patients with schizophrenia but also ...

ARVO: Genetic link ID'd for strabismus and schizophrenia

May 5, 2015
(HealthDay)—There is a genetic link for strabismus and schizophrenia, with almost half of the genes dysregulated in strabismic medial rectus muscle identified as biomarkers for schizophrenia, according to a study presented ...

Recommended for you

Researchers develop new tool to assess individual's level of wisdom

September 20, 2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual's level of wisdom, based upon a conceptualization of wisdom as a trait ...

Alcohol use affects levels of cholesterol regulator through epigenetics

September 20, 2017
In an analysis of the epigenomes of people and mice, researchers at Johns Hopkins Medicine and the National Institutes of Health report that drinking alcohol may induce changes to a cholesterol-regulating gene.

One in four girls is depressed at age 14, new study reveals

September 20, 2017
New research shows a quarter of girls (24%) and one in 10 boys (9%) are depressed at age 14.

Tablets can teach kids to solve physical puzzles

September 20, 2017
Researchers confirm that when 4-6 year old children learn how to solve a puzzle using a touchscreen tablet, they can then apply this learning to the same puzzle in the physical world. This contradicts most previous research ...

Behavioral therapy increases connectivity in brains of people with OCD

September 19, 2017
UCLA researchers report that people with obsessive-compulsive disorder, when treated with a special form of talk therapy, demonstrate distinct changes in their brains as well as improvement in their symptoms.

People with schizophrenia have threefold risk of dying

September 18, 2017
People with schizophrenia are three times more likely to die, and die younger, than the general population, indicating a need for solutions to narrow this gap, according to research published in CMAJ (Canadian Medical Association ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.